Larin Fe 1.5/30

Endometriosis, Low Testosterone, Osteoporosis + 16 more

Treatment

20 Active Studies for Larin Fe 1.5/30

Treatment for

Endometriosis

What is Larin Fe 1.5/30

NorethisteroneThe Generic name of this drug

Treatment SummaryNorethisterone (also known as norethindrone) is a synthetic form of the hormone progestogen. This hormone is commonly prescribed to treat irregular menstrual periods, endometriosis, and used as part of contraception and hormone replacement therapy. Norethisterone was first developed in 1951 and used as an oral contraceptive in 1962. It is a more powerful form of progesterone than the body produces naturally.

Neconis the brand name

image of different drug pills on a surface

Larin Fe 1.5/30 Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Necon

Norethisterone

1967

347

Effectiveness

How Larin Fe 1.5/30 Affects PatientsNorethisterone is a synthetic hormone taken either for contraception or to treat hormone-related conditions. It works similarly to the body's natural progesterone but is much more powerful. Norethisterone acts in the pelvis to change how the cervix and uterus work, as well as by blocking hormones that affect the development of eggs. There is a slight increase in the risk of breast cancer when using this medication, so it is important that patients be aware of this risk and do regular self-examinations.

How Larin Fe 1.5/30 works in the bodyNorethisterone is a hormone that affects the reproductive system. It thickens the cervical mucus to stop sperm from entering the uterus and thins the endometrium so a fertilized egg cannot implant. Norethisterone also works to decrease the hormones that cause an egg to be released from an ovary. This helps to prevent pregnancy. Additionally, when used as part of hormone replacement therapy in menopausal women, norethisterone can protect against endometrial hyperplasia, which is linked to an increased risk of cancer. Norethisterone does not have a major effect on other steroid receptors like

When to interrupt dosage

The recommended dosage of Larin Fe 1.5/30 hinges upon the diagnosed condition, such as Atrophic, Fracture and Hormone Replacement Therapy. The amount of dosage fluctuates, based on the method of administration (e.g. Oral or Tablet) featured in the table below.

Condition

Dosage

Administration

Hot flashes

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Atrophic

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Hormone Replacement Therapy

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

female castration

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Endometriosis

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Low Testosterone

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

hypoestrogenism

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Therapeutic procedure

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Fracture

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Ovarian Failure

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Postmenopausal Osteoporosis

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Vasomotor System

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Oral Contraceptives

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Hormonal Contraception

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Estrogen Deprivation Symptoms

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Menopause

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Birth Control

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Osteoporosis

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Endometriosis

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Warnings

Larin Fe 1.5/30 has 8 prohibitions; therefore, it should not be consumed in conjunction with the conditions stipulated in the following table.Larin Fe 1.5/30 Contraindications

Condition

Risk Level

Notes

active liver disease

Do Not Combine

Thrombophilia

Do Not Combine

Vaginal Hemorrhage

Do Not Combine

Malignant Neoplasms

Do Not Combine

Benign hepatic neoplasm

Do Not Combine

Breast Cancer

Do Not Combine

Thromboembolism

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Norethisterone may interact with Pulse Frequency

There are 20 known major drug interactions with Larin Fe 1.5/30.

Common Larin Fe 1.5/30 Drug Interactions

Drug Name

Risk Level

Description

Astemizole

Major

The metabolism of Astemizole can be decreased when combined with Norethisterone.

Axitinib

Major

The metabolism of Axitinib can be decreased when combined with Norethisterone.

Cabazitaxel

Major

The metabolism of Cabazitaxel can be decreased when combined with Norethisterone.

Clomipramine

Major

The metabolism of Clomipramine can be increased when combined with Norethisterone.

Copanlisib

Major

The metabolism of Copanlisib can be decreased when combined with Norethisterone.

Larin Fe 1.5/30 Toxicity & Overdose RiskThe lowest toxic dose of oral contraceptives in mice has been found to be 6g/kg, and the lowest dose in women is 42mg/kg. There are no reports of serious side effects from taking too much of these contraceptives, even in children. Symptoms of overdose may include severe nausea and vomiting.

image of a doctor in a lab doing drug, clinical research

Larin Fe 1.5/30 Novel Uses: Which Conditions Have a Clinical Trial Featuring Larin Fe 1.5/30?

160 active clinical trials are presently assessing the potential of Larin Fe 1.5/30 to provide Birth Control, Atrophic and Testosterone Replacement Therapy.

Condition

Clinical Trials

Trial Phases

Endometriosis

31 Actively Recruiting

Phase 3, Not Applicable, Early Phase 1, Phase 2, Phase 4, Phase 1

Oral Contraceptives

2 Actively Recruiting

Not Applicable

Hot flashes

22 Actively Recruiting

Phase 2, Not Applicable, Phase 1, Phase 4, Early Phase 1

Therapeutic procedure

0 Actively Recruiting

Menopause

0 Actively Recruiting

Hormone Replacement Therapy

0 Actively Recruiting

Osteoporosis

41 Actively Recruiting

Phase 1, Phase 2, Not Applicable, Early Phase 1, Phase 4, Phase 3

Postmenopausal Osteoporosis

2 Actively Recruiting

Not Applicable

Low Testosterone

16 Actively Recruiting

Phase 1, Phase 4, Phase 2, Not Applicable

Estrogen Deprivation Symptoms

0 Actively Recruiting

Birth Control

28 Actively Recruiting

Not Applicable, Phase 3, Phase 4, Early Phase 1

Atrophic

5 Actively Recruiting

Phase 4, Not Applicable

Fracture

0 Actively Recruiting

female castration

0 Actively Recruiting

hypoestrogenism

2 Actively Recruiting

Phase 4

Vasomotor System

0 Actively Recruiting

Endometriosis

1 Actively Recruiting

Phase 4

Ovarian Failure

2 Actively Recruiting

Not Applicable, Phase 1

Hormonal Contraception

0 Actively Recruiting

Larin Fe 1.5/30 Reviews: What are patients saying about Larin Fe 1.5/30?

5Patient Review

10/20/2014

Larin Fe 1.5/30 for Birth Control

This medicine helped me to regulate my heavy periods, but I found that it also made me feel constantly tired, upset, and caused me to gain weight. I'm not sure if all the side effects are worth it.

5Patient Review

1/31/2017

Larin Fe 1.5/30 for Birth Control

I unfortunately experienced some negative side effects like rashes and headaches. My blood pressure also increased.

4.7Patient Review

1/25/2019

Larin Fe 1.5/30 for Painful Periods

I switched to this treatment after my old one stopped being effective and I started having painful cycles again. So far, no negative side effects that I've noticed. The packaging could be better designed--the pills sometimes pop out too forcefully and it's easy to drop them.

4Patient Review

8/22/2019

Larin Fe 1.5/30 for Abnormally Long or Heavy Periods

I was pretty tired and felt nauseous the first week I took Larin Fe 1/20. However, I've been spotting on and off since then and it's a vast improvement from my natural period (which involved gushing and heavy flow). So overall, I'm pleased.

4Patient Review

8/22/2019

Larin Fe 1.5/30 for Abnormally Long or Heavy Periods

I was pretty tired and nauseous the first week I took Larin Fe 1/20, but it was worth it. I barely need a liner now when I'm on my period, which is such a huge improvement from before.

3.7Patient Review

9/29/2014

Larin Fe 1.5/30 for Abnormal Bleeding from the Uterus

Though this medication has largely stopped my heavy bleeding, I still experience some spotting every day. Additionally, I have high blood pressure for which I take three separate medications. The only reaction that I know of so far from taking Larin FE is rashes. My right eye was blind for at least one minute. Then the right side of head hurts and my nostril. I don't know what caused this.

3.7Patient Review

5/9/2014

Larin Fe 1.5/30 for Abnormally Long or Heavy Periods

3.7Patient Review

2/17/2018

Larin Fe 1.5/30 for Birth Control

This treatment is effective with no negative side effects that I've experienced.

3Patient Review

4/2/2015

Larin Fe 1.5/30 for Acne

Really didn't have any negative effects from this. Only good things to report!

3Patient Review

9/5/2022

Larin Fe 1.5/30 for Abnormally Long or Heavy Periods

I've been on this birth control for a month and it's helped with my period. I get migraines every day, but hopefully that will go away after a few more months.

image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about larin fe 1.5/30

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Larin 1.5 30 A combination pill?

"The LARINTM 1.5/30 is a hormonal contraceptive that contains a combination of the progestogen and estrogen."

Answered by AI

What kind of birth control is Larin Fe?

"Larin 24 Fe is a combination oral contraceptive containing active tablets with norethindrone acetate (progestin) and ethinyl estradiol (estrogen), and placebo tablets with ferrous fumarate (un medically active ingredient)."

Answered by AI

What are the side effects of Larin Fe 1.5 30?

"The following are possible side effects: feeling nauseous, vomiting, abdominal cramps and bloating, spotting, changes in menstrual flow, skin discoloration, breast tenderness or enlargement, nipple discharge."

Answered by AI

Does Larin Fe 1.5 30 prevent pregnancy?

"The Larin Fe 1.5/30 pill is taken by women who want to prevent pregnancy and is an oral contraceptive. Oral contraceptives are very effective in preventing pregnancy."

Answered by AI

Clinical Trials for Larin Fe 1.5/30

Image of Hebrew SeniorLife in Roslindale, United States.

Synbiotic for Osteoporosis

This trial will test if a combination of probiotics and prebiotics can improve bone health in older women.

Waitlist Available

Senior-friendly

Hebrew SeniorLifeShivani Sahni, PhDSolarea Bio, Inc

Image of University of Colorado Department of Obstetrics & Gynecology in Aurora, United States.

Elagolix for Infertility

This trial is testing a new medication given by mouth to women with endometriosis who are trying to get pregnant through IVF. The main goal is to see if the medication can increase the chances

University of Colorado Department of Obstetrics & Gynecology (+4 Sites)Hugh Taylor, MD

Image of University of Michigan in Ann Arbor, United States.

My Pelvic Plan Website for Endometriosis

This trial aims to see if an online self-management program can help patients with Chronic Pelvic Pain feel better. The researchers believe that patients using the program will have less pain, better physical function, and

Waitlist Available

University of MichiganSara Till, MD

Image of University of Colorado Anschutz Medical Campus in Aurora, United States.

Desogestrel / Ethinyl Estradiol Pill for Birth Control

This trial aims to understand how differences in our DNA can affect how our bodies process hormones in birth control pills, potentially influencing their effectiveness in preventing pregnancy and causing different side effects in individuals. Participants will take

Waitlist Available

University of Colorado Anschutz Medical Campus (+1 Sites)Aaron M Lazorwitz, MD, PhD

Have you considered Larin Fe 1.5/30 clinical trials? We made a collection of clinical trials featuring Larin Fe 1.5/30, we think they might fit your search criteria.

Explore trials for Larin Fe 1.5/30

Image of University of California, San Francisco in San Francisco, United States.

Advancing Access Website for Birth Control

San Francisco, CA

This trial aims to see if providing information to women who want to avoid pregnancy about tubal sterilization and long-acting reversible contraceptives helps them access contraceptives better. Participants will fill out

Waitlist Available

University of California, San FranciscoEleanor Schwarz, MD, MS

Image of University of Central Florida in Orlando, United States.

Wrist/hand immobilization for Menstruation

"This trial aims to understand why females tend to get more hand and wrist injuries compared to males in sports. The study will look at the impact of hormones, such as those from birth control, on muscle

University of Central Florida

Image of University of Colorado Anschutz Medical Campus in Aurora, United States.

Transdermal Estradiol Patch +2 More for Menopause

"This trial aims to study how the decrease in estrogen during menopause affects artery health and body fat distribution in women. The researchers will investigate whether low estrogen levels lead to decreased artery function and increased fat in

Waitlist Available

University of Colorado Anschutz Medical CampusKerrie Moreau, PhD

Image of University of Kentucky in Lexington, United States.

Alendronate for Osteoporosis

This trial aims to address the issue of age-related bone loss, which is often overlooked in current osteoporosis treatments. The study compares the effectiveness of two drugs, Alendronate and Terip

Waitlist Available

University of KentuckyHartmut H Malluche, MD

Have you considered Larin Fe 1.5/30 clinical trials? We made a collection of clinical trials featuring Larin Fe 1.5/30, we think they might fit your search criteria.

Explore trials for Larin Fe 1.5/30

Image of Brigham and Women's Hospital in Boston, United States.

Time-restricted Eating for Menopause

This trial aims to see how restricting eating to only an 8-hour window each day affects the levels of fats in the blood and the composition of the body in women who are going through or have recently

Brigham and Women's HospitalLeilah K Grant, PhD

Image of University of Arizona in Tucson, United States.

PhytoSERM for Hot Flashes

This trial is testing the effects of a supplement called PhytoSERM on menopausal symptoms in women. Participants will either take PhytoSERM pills or a placebo for 12 weeks. After

University of ArizonaFei Yin, PhDNeuTherapeutics

Image of Citruslabs in Santa Monica, United States.

Probiotic Supplement for Menopause Symptoms

Santa Monica, CA

This trial tests if a probiotic supplement can reduce menopause symptoms like hot flashes, night sweats, mood swings, etc. Participants take a test product or placebo daily and provide data on weight, waist, sleep, and symptoms.

Waitlist Available

Dietary Supplement

CitruslabsManeuver Marketing

Image of Planned Parenthood of Northern California in Berkeley, United States.

Ovaprene for Birth Control

This trial will study a new, non-hormonal contraceptive ring for safety, effectiveness, and acceptability.

Planned Parenthood of Northern California (+20 Sites)Christine Mauck, MDDaré Bioscience, Inc.

Have you considered Larin Fe 1.5/30 clinical trials? We made a collection of clinical trials featuring Larin Fe 1.5/30, we think they might fit your search criteria.

Explore trials for Larin Fe 1.5/30

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.

Back to top

Terms of Service Privacy Policy Security